The platform, called OptiVax, focuses on developing peptide vaccines, which are a different approach from common whole virus, DNA, and RNA vaccines currently among the more than 100 vaccines in development. 1
Peptide vaccines use a synthetic version of the peptide that is created in a laboratory and not harvested from the disease itself. 1

TL;DR as a service

Highlight the Internet and share on social media